Mike Pellini, MD
General Partner at Section 32
About
Former CEO of Foundation Medicine, which transformed how oncologists and pharmaceutical companies evaluate cancer's genomic drivers before Roche's 2018 acquisition. Previously President and COO of Clarient, acquired by GE Healthcare. Brings three decades of expertise in personalized medicine and cancer research.
Colleagues at Section 32
Alice Cheung
Partner, Talent at Section 32
Allison Pavlick
Investor Relations Principal at Section 32
Andrew Conrad, PhD
General Partner at Section 32
Andy Harrison
General Partner, CEO at Section 32
Ayesha Arora
Venture Partner at Section 32
Bayan Alizadeh
Partner at Section 32
Bill Maris
General Partner, Founder at Section 32
Derrick Chow
Partner at Section 32